Can a drug calm severe eczema itch when the rash is mild? a new study investigates
NCT ID NCT06192563
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study looks at teenagers aged 12 to 17 who have severe atopic dermatitis (eczema) with intense itching but only a mild to moderate rash. They are being treated with dupilumab (Dupixent), a standard medication. The goal is to see how well dupilumab controls itching, improves sleep and quality of life, and affects eczema in sensitive areas like the face, hands, and genitals. Researchers will follow participants for 52 weeks to track these outcomes in real-world settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dupilumab (Dupixent)
What this could lead to
If successful, this could show that dupilumab helps teens with severe itching even when their eczema rash is not widespread, improving sleep, daily life, and sensitive skin areas.
What could go wrong
This is an observational study, not a controlled trial, so results may be less definitive. It is also limited to a specific group of teens in Italy, so findings may not apply to everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS, ATOPIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Investigational Site Number: 001
RECRUITINGMilan, 20122, Italy
-
Investigational Site Number: 002
RECRUITINGBologna, 40138, Italy
-
Investigational Site Number: 004
RECRUITINGFlorence, 50139, Italy
-
Investigational Site Number: 005
RECRUITINGRoma, 00133, Italy
-
Investigational Site Number: 006
RECRUITINGBrescia, 25123, Italy
-
Investigational Site Number: 009
RECRUITINGRoma, 00168, Italy
-
Investigational Site Number: 010
RECRUITINGNaples, 80131, Italy
-
Investigational Site Number: 011
RECRUITINGNaples, 80138, Italy
-
Investigational Site Number: 014
RECRUITINGVerona, 37134, Italy